Merck, the world’s oldest pharma and chemical company, has implemented several diversity and inclusion initiatives across the organisation aimed at helping women network and mentor each other. Merck first introduced mentoring and cross-cultural trainings in the year 2000, and over the following 10 years this led to a special focus on diversity and women in…
China based conglomerate AUX Group has announced plans to seek health services investments in the US and Britain, according to recent reports. The company has 8.2 billion USD in total assets and was named among China’s top 500 enterprises. The announcement comes after AUX Group’s planned 2.7 billion AUD investment into Healthscope, the second-largest operator…
Tech companies around the world are among the many businesses benefiting from the recent flood of Chinese overseas direct investment. Tsinghua Holdings, a Chinese state-owned company, has recently disclosed an investment in Marvell Technology Group, a chip maker based in Silicon Valley. Although the size of the investment has not been specified, Tsinghua reported the…
When oil prices went into freefall in the winter of 2015, bringing a dramatic end to 18 months of gradual depreciation, few could have predicted the full impact it would have on economies around the GCC. Initial optimism saw governments around the region predicting an initial 6-month readjustment period before oil prices returned to higher…
In May 2016, Chinese investment group Creat Group agreed to acquire UK-based Bio Products Laboratory for 820 million GBP (1.1 billion USD). Headquartered in Hertfordshire, Bio Products Laboratory is a plasma biotherapeutics company that provides therapeutics for conditions related to bleeding disorders, immune deficiencies and critical care. Creat will invest an additional 100 million GBP…
Chinese investors specializing in healthcare are increasingly expanding into the European market with a series of high-profile, strategic investments. This is part of a trend of heightened healthcare deal activity from Chinese investors. Last year, companies based in China announced acquisitions in the medical industry worth 30.4 billion USD – representing twice the investment level…
The Middle East is experiencing rising demand for high quality, innovative healthcare solutions. This is particularly true for the region’s largest healthcare market – Saudi Arabia. Saudi entities are increasingly willing to invest in healthcare companies overseas in order to source solutions and expertise that could meet the needs of the Saudi market. Healthcare is…
Investors based in the Middle East and regional healthcare companies having been actively seeking acquisitions and investment opportunities in the US. Overseas investments provide Middle Eastern individuals and institutions with a way to diversify their portfolios, rather than overexposing their operations to a single market, as noted recently in Forbes. According to Dhiraj Joshi, a…
Earlier this year, the pharmaceutical arm of Fosun International, a Chinese company with a market cap of over 13 billion USD, announced a1.3 billion USD buyout of India based Gland Pharma. Chinese companies are increasingly making healthcare deals abroad in order to become relevant and active players in the global healthcare market. The domestic market…
I-Bridge Capital, a health-care focused venture capital firm and incubator based in Shanghai, has announced the establishment of a joint venture with BioLineRx Ltd., a drug company based in Israel. The venture will incubate healthcare startups, in order to develop innovative clinical and pre-clinical therapeutic projects. Though these projects will originate primarily in Israel, they…